false

Eva Raschke

Eva Raschke, PhD serves as a subject matter expert for immune monitoring solutions at Precision for Medicine with a focus on the epigenetic immune monitoring technology Epiontis ID. She has supported the development, validation and clinical use of this technology platform in different roles since 2008. Eva obtained a Ph.D. in Molecular Biology from the Ludwig-Maximilians-University Munich.

• Read: Precision Medicine in Pediatrics: Biomarkers and Assay Development

  Translational Research - Biomarkers

  Precision Medicine in Pediatrics: Biomarkers and Assay Development

  May 24, ‘24 | 8 min read

  • 

    Eva Raschke

  Discover
• Read: Conducting Pediatric Studies: Addressing Ethical and Clinical Challenges

  Clinical Trials - Translational Research - Regulatory

  Conducting Pediatric Studies: Addressing Ethical and Clinical Challenges

  Oct 23, ‘23 | 7 min read

  • 

    Eva Raschke

  Discover
• Read: Methods for a Comprehensive Characterization of the Tumor Microenvironment

  Translational Research

  Methods for a Comprehensive Characterization of the Tumor Microenvironment

  Jun 12, ‘23 | 5 min read

  • 

  • Eva R.

    Jesus G.

    Jie Y.

  Discover
• Read: Characterizing a Central Switch of Immune Suppression: Monitoring Treg Cells in Clinical Studies

  Translational Research

  Characterizing a Central Switch of Immune Suppression: Monitoring Treg Cells in Clinical Studies

  Dec 13, ‘22 | 6 min read

  • 

    Eva Raschke

  Discover
• Read: Using Epigenetic Immunophenotyping to Explore Potential Biomarkers in Hepatocellular Carcinoma

  Translational Research

  Using Epigenetic Immunophenotyping to Explore Potential Biomarkers in Hepatocellular Carcinoma

  Aug 04, ‘22 | 2 min read

  • 

    Eva Raschke

  Discover
• Read: Non-Invasive Immune Monitoring to Predict COVID-19 Disease Course and Assess SARS-CoV-2 Vaccine Response

  Translational Research

  Non-Invasive Immune Monitoring to Predict COVID-19 Disease Course and Assess SARS-CoV-2 Vaccine Response

  Jul 22, ‘22 | 2 min read

  • 

    Eva Raschke

  Discover
• Read: Next-Generation Immune Monitoring in Immuno-oncology Trials

  Translational Research

  Next-Generation Immune Monitoring in Immuno-oncology Trials

  Mar 17, ‘21 | 3 min read

  • 

  • Eva R.

    Ulrich H.

  Discover

Loading...

You've reach the end Back to top